Grants and Contributions:
Title:
Oxy 2.0
Agreement Number:
937540
Agreement Value:
$337,900.00
Agreement Date:
Oct 25, 2019 - Feb 28, 2021
Description:
Southmedic is developing a second generation of its Oxymask O2 and ETCO2 products, which are based on the same underlying technology. The second generation significantly improves the clinical effectiveness of the product without compromising any of the benefits of the first-generation product.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Barrie, Ontario, CA L4M 5K3
Reference Number:
172-2019-2020-Q3-937540
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
125544999
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 121 days.
Amendment Date
Jul 23, 2020
Recipient's Legal Name:
Southmedic Inc.
Federal Riding Name:
Barrie--Springwater--Oro-Medonte
Federal Riding Number:
35005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: